US Broker Ratings

AbCellera Biologics Inc. (ABCL) Stock Analysis: Unpacking the 139% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology firm, is making waves in the healthcare sector with an impressive potential upside of 139.25%. With a market capitalization of $1.23 billion,..

uniQure N.V. (QURE) Stock Analysis: A Biotech Powerhouse with 137% Potential Upside

uniQure N.V. (NASDAQ: QURE), a pioneering entity in the biotechnology sector, is making waves with its innovative gene therapy solutions targeting rare and debilitating diseases. With a market cap of..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: High Growth Potential with an 83.77% Upside

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a key player in the biotechnology sector, has been making waves in the healthcare industry with its innovative cancer therapies. With a market capitalization of..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A 27.73% Potential Upside in the Biotech Sector

Sionna Therapeutics, Inc. (SION) is generating buzz in the biotechnology sector with its focus on developing innovative treatments for cystic fibrosis (CF). With a market capitalization of $1.63 billion, this..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Uncovering a 105% Upside Potential in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is a notable player in the biotechnology industry, attracting investor attention with its ambitious pipeline and impressive potential upside. As a clinical-stage biopharmaceutical company based..

Fulgent Genetics, Inc. (FLGT) Stock Report: Analyzing a 20.71% Potential Upside in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector, specifically within diagnostics and research, is attracting attention from investors due to its promising potential upside of 20.71%...

CareDx, Inc. (CDNA) Stock Analysis: Navigating a 33.57% Potential Upside in Transplant Diagnostics

For investors seeking exposure to the burgeoning healthcare sector, CareDx, Inc. (NASDAQ: CDNA) presents an intriguing opportunity within the diagnostics and research industry. With its headquarters nestled in South San..

Arcus Biosciences, Inc. (RCUS) Investor Outlook: Exploring a 48.95% Upside Potential

Arcus Biosciences, Inc. (NASDAQ: RCUS), a key player in the biotechnology sector, has captured the attention of investors with its ambitious cancer therapy pipeline and significant upside potential. Based in..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring Its Potential 35.79% Upside

Nutex Health Inc. (NUTX), a Houston-based healthcare services and operations company, has recently caught the attention of investors with its impressive revenue growth and promising analyst ratings. Operating across the..

Embecta Corp. (EMBC): Investor Outlook Reveals 30.62% Potential Upside Amidst Mixed Ratings

Embecta Corp. (NASDAQ: EMBC), a pivotal player in the healthcare sector’s medical instruments and supplies industry, has been making waves with its specialized focus on diabetes management solutions. Headquartered in..

Immunome, Inc. (IMNM) Stock Analysis: Exploring a 67% Potential Upside in the Biotech Sector

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology firm rooted in the development of targeted cancer therapies, has captured the attention of investors with its promising pipeline and significant market potential...

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Biotechnology Innovator with 112% Potential Upside

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering player in the biotechnology sector, has captured the attention of investors with its groundbreaking work in genome editing. With a market capitalization of..

iRadimed Corporation (IRMD) Stock Analysis: Strong Revenue Growth in the Medical Device Sector

iRadimed Corporation (NASDAQ: IRMD) has positioned itself as a noteworthy player in the medical devices sector, particularly in the niche of MRI-compatible equipment. With a market capitalization of $1.27 billion,..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Unveiling an 83.84% Potential Upside in the Biotech Arena

Bicara Therapeutics Inc. (BCAX) is making waves in the biotechnology sector with a compelling narrative that carries significant potential for investors eyeing the healthcare industry. Based in Boston, Massachusetts, and..

SI-BONE, Inc. (SIBN) Investor Outlook: 23.99% Potential Upside and Strong Buy Ratings Fuel Growth Expectations

SI-BONE, Inc. (NASDAQ: SIBN) is capturing investor attention in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $906.01 million, the company is strategically positioned..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Opportunities with an 18% Potential Upside

As STAAR Surgical Company (NASDAQ: STAA) continues to make strides in the healthcare sector, investors are keenly observing the developments within this medical instruments and supplies company. With a market..

Gyre Therapeutics, Inc. (GYRE) Stock Report: A Biotech Gem with a Potential 137% Upside

For investors seeking opportunities in the biotechnology sector, Gyre Therapeutics, Inc. (NASDAQ: GYRE) presents an intriguing prospect, particularly with a potential upside of 137.78%. Specializing in the development of small-molecule..

Dynatrace, Inc. (DT) Stock Analysis: Exploring a 37% Potential Upside for Investors

Dynatrace, Inc. (NYSE: DT), a formidable player in the technology sector, specifically within the software application industry, presents a compelling investment opportunity with a promising potential upside of 37.36%. Headquartered..

Similarweb Ltd. (SMWB) Stock Analysis: Eyeing a 68.6% Upside with Strong Buy Ratings

As investors scour the technology sector for promising opportunities, Similarweb Ltd. (NASDAQ: SMWB) emerges as a compelling contender. This Israel-based software application company, renowned for its digital data and analytics..

Procore Technologies, Inc. (PCOR) Stock Analysis: Unpacking a 16.52% Potential Upside

Procore Technologies, Inc. (NYSE: PCOR) has steadily carved out a niche in the technology sector, specifically within the application software industry. With a robust market capitalization of $11.6 billion, this..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds